公开(公告)号：US11257080B2

公开(公告)日：2022-02-22

申请号：US17201835

申请日：2021-03-15

申请人： Michael Sasha John

发明人： Michael Sasha John

IPC分类号： G06Q20/40 ,  G06Q30/06 ,  G06Q40/00 ,  G06Q20/12 ,  G06Q20/42 ,  G06F21/32 ,  G06F21/35 ,  G06F21/60 ,  G06F21/62 ,  G06Q20/38

摘要： An illustrative fraud deterrent method includes presenting an identity verification option for a first website displayed in a web-browser, the option including offering a login to a third-party website, unrelated to the first website. The method further includes receiving login information for a first user account on the third-party website and verifying the login information through a verification service associated with the third-party website, to verify that the login information is valid for the first user account, identified by the login information. The method additionally includes verifying an identity at the first website, responsive to the verification.

公开(公告)号：US20210110448A1

公开(公告)日：2021-04-15

申请号：US17107629

申请日：2020-11-30

申请人： Michael Sasha John

发明人： Michael Sasha John

IPC分类号： G06Q30/06 ,  G06Q20/40

摘要： Systems and methods are described for providing fraud deterrents, detection and prevention during e-commerce, e-transactions, digital rights management and access control. Fraud deterrent levels may be automatically selected by a requesting transaction approval entity server (and can be related to level of risk, or security, related to fraud) or may be selected by a consumer. These deterrent levels can determine the manner in which the transaction occurs as well as the types of information that must be provided and validated for successful approval of the transaction. The client can associate their credit card with a specific device, an e-identity, such as an instant messaging identity, and the e-identity is contacted as a part of finalizing a payment transaction so that a client response of ‘approve’ or ‘reject’ can be obtained. The anti-fraud technology also provides for management and storage of historical transaction information. Entity-to-client communication occurs according to merchant permission parameters which are defined by the client and which enable messages sent by the entity to be automatically allowed, rejected, and managed in other ways as well.

公开(公告)号：US10853855B2

公开(公告)日：2020-12-01

申请号：US12124144

申请日：2008-05-20

申请人： Michael Sasha John

发明人： Michael Sasha John

IPC分类号： G06Q30/06 ,  G06Q20/40

摘要： Systems and methods are described for providing fraud deterrents, detection and prevention during e-commerce, e-transactions, digital rights management and access control. Fraud deterrent levels may be automatically selected by a requesting transaction approval entity server (and can be related to level of risk, or security, related to fraud) or may be selected by a consumer. These deterrent levels can determine the manner in which the transaction occurs as well as the types of information that must be provided and validated for successful approval of the transaction. The client can associate their credit card with a specific device, an e-identity, such as an instant messaging identity, and the e-identity is contacted as a part of finalizing a payment transaction so that a client response of ‘approve’ or ‘reject’ can be obtained. The anti-fraud technology also provides for management and storage of historical transaction information. Entity-to-client communication occurs according to merchant permission parameters which are defined by the client and which enable messages sent by the entity to be automatically allowed, rejected, and managed in other ways as well.

公开(公告)号：US10589024B2

公开(公告)日：2020-03-17

申请号：US15925723

申请日：2018-03-19

申请人： Michael Sasha John

发明人： Michael Sasha John

IPC分类号： A61M5/168 ,  A61B5/00 ,  A61M5/142 ,  A61M5/172 ,  A61M25/00 ,  G06F19/00 ,  A61M5/14 ,  G16H20/17 ,  A61B5/145

摘要： A drug delivery system provides for controlled mixing of drugs, using at least one mixing chamber. Flow controllers guide drugs into single or multiple catheters, enabling a single lumen catheter to dispense multiple drugs, diluting a concentrated drug to provide varying drug concentration. A buffer fluid can deliver precise drug amounts or can separate drugs within a catheter. A patient's bodily fluid can serve as a diluent or buffer fluid. A drug testing/filler apparatus may be used to facilitate filling of multiple reservoirs. Bolus or continuous delivery of drug to selected distal locations can occur at independent rates. New catheter systems, hub assemblies, and uses therefore are also described. New methods for promotion of healthy pregnancy and treatment of a developing fetus are disclosed.

公开(公告)号：US10322294B2

公开(公告)日：2019-06-18

申请号：US14474289

申请日：2014-09-01

申请人： Michael Sasha John

发明人： Michael Sasha John

IPC分类号： A61N1/05 ,  A61N2/00 ,  A61N1/36 ,  A61N2/02

摘要： Stimulation treatments for medical disorders comprise providing stimulation parameters that create partial stimulation signals which combine into vector signals. The individual partial signals may have frequency or temporal content that is unique rather than all being identical. Vector signals may thus be designed with certain advantageous characteristics such as to influence target tissue in an intended manner while partial signals may be designed with other advantageous characteristics such as to avoid producing side effects in adjacent tissue. Roving of stimulation parameters can be designed to influence partial signals, vectors signals, or both. Partial and vector signals may be designed to match or avoid internal/endogenous activity patterns and rhythms of a patient. Methods for choosing, creating and using partial signals are disclosed. Tissue modulation may be accomplished with electrical and/or magnetic stimulation.

公开(公告)号：US20190134402A1

公开(公告)日：2019-05-09

申请号：US16241524

申请日：2019-01-07

申请人： Michael Sasha John

发明人： Michael Sasha John

IPC分类号： A61N1/36 ,  A61N1/372

CPC分类号： A61N1/36178 ,  A61M5/14276 ,  A61M5/172 ,  A61M5/1723 ,  A61N1/0456 ,  A61N1/0529 ,  A61N1/36064 ,  A61N1/36071 ,  A61N1/36082 ,  A61N1/36114 ,  A61N1/37235

摘要： Stimulation treatments for various medical disorders, such as neurological disorders, comprise novel systems, strategies, and methods for providing TMS, electrical, magnetic, optical and other stimulation modalities. Some stimulation methods comprise varying the stimulation parameters to improve the therapeutic efficacy of stimulation, and decrease risk of habituation and side-effects such as interference with normal brain, sensory, motor, and cognitive processes. The creation, and subsequent variation, of stimulation parameters can use sensed data in order to match, adjust, or avoid matching characteristics of the stimulation therapy relative to certain endogenous brain activities. Novel methods are described for choosing, creating and subsequently stimulating with partial signals which summate to produce therapeutic vector fields having unique temporal patterns and low- or high-frequency spectral content. Improvements for the treatment of pain are disclosed.

公开(公告)号：US20170124571A1

公开(公告)日：2017-05-04

申请号：US15404184

申请日：2017-01-11

申请人： Michael Sasha John

发明人： Michael Sasha John

IPC分类号： G06Q20/40

CPC分类号： G06Q20/4016 ,  G06F21/32 ,  G06F21/35 ,  G06F21/606 ,  G06F21/6263 ,  G06Q20/123 ,  G06Q20/382 ,  G06Q20/4012 ,  G06Q20/40145 ,  G06Q20/405 ,  G06Q20/409 ,  G06Q20/425 ,  G06Q30/06 ,  G06Q30/0601 ,  G06Q30/0613 ,  G06Q40/00

摘要： Systems and methods are described for providing fraud deterrents during payment card transactions especially for e-commerce and e-transactions. Fraud deterrents may be selected and configured by a client, bank, or other third-party and provided to a client in customized manners which may be configured on a client's authorized device Or otherwise as defined in an e-profile associated with a payment card. Fraud deterrent options may be contingent upon transaction features including a client's profile, transaction value, or other preferences. The deterrent features may be customized by the client and include use of conceptual passwords.

公开(公告)号：US09089713B2

公开(公告)日：2015-07-28

申请号：US11877897

申请日：2007-10-24

申请人： Michael Sasha John

发明人： Michael Sasha John

IPC分类号： A61N1/05 ,  A61N1/372 ,  A61N1/36 ,  A61B5/00 ,  G06F19/00

CPC分类号： G06F19/3468 ,  A61B5/00 ,  A61B5/4082 ,  A61B5/4094 ,  A61B5/4809 ,  A61B5/4812 ,  A61B5/4818 ,  A61M5/142 ,  A61M5/14276 ,  A61M5/172 ,  A61M5/1723 ,  A61M2005/14208 ,  A61M2205/18 ,  A61M2230/005 ,  A61M2230/201 ,  A61M2230/63 ,  A61N1/3605 ,  A61N1/36082 ,  A61N1/37235 ,  A61N1/37247 ,  A61N1/37258 ,  G06F19/00 ,  G06F19/325 ,  G06F19/3481 ,  G16H40/63 ,  G16H50/20

摘要： Systems and methods are described for adjusting the operation of implantable stimulation devices used to provide medical monitoring and treatment. Several hierarchical algorithms are described which operate according to conditionally obtaining a patient response to an alert signal. In one such strategy semi-automatic therapy adjustment occurs by automatically issuing patient alert messages when selected operations are to occur, and using a patient's response to the alert message that is provided within a selected time limit in order to contingently adjust therapy. Methods are also described for resolving conflicts which may occur when time information and sensed data information each indicate different patient states are occurring. Although treatment of neural and cardiac disorders is emphasized, the techniques can be applied to the monitoring and treatment of any medical disorder with an implanted device.

公开(公告)号：US08831735B2

公开(公告)日：2014-09-09

申请号：US11933310

申请日：2007-10-31

申请人： Michael Sasha John

发明人： Michael Sasha John

IPC分类号： A61N1/00 ,  A61N1/372 ,  A61B5/00

CPC分类号： A61N1/37247 ,  A61B5/00 ,  A61B5/4082 ,  A61B5/4094 ,  A61B5/4809 ,  A61B5/4812 ,  A61B5/4818 ,  A61N1/37258

摘要： Systems and methods are described for adjusting the operation of implantable stimulation devices used to provide medical monitoring and treatment. Several hierarchical algorithms are described which operate according to conditionally obtaining a patient response to an alert signal. In one such strategy semi-automatic therapy adjustment occurs by automatically issuing patient alert messages when selected operations are to occur, and using a patient's response to the alert message that is provided within a selected time limit in order to contingently adjust therapy. Methods are also described for resolving conflicts which may occur when time information and sensed data information each indicate different patient states are occurring. Although treatment of neural and cardiac disorders is emphasized, the techniques can be applied to the monitoring and treatment of any medical disorder with an implanted device.

摘要翻译： 描述了用于调整用于提供医疗监测和治疗的可植入刺激装置的操作的系统和方法。 描述了根据有条件地获得对警报信号的患者响应进行操作的几种分级算法。 在一种这样的策略中，半自动治疗调整是通过在选择的操作发生时自动发出病人警报消息，并且使用患者对在所选时限内提供的警报消息的响应来偶然地调整治疗。 还描述了用于解决当时间信息和感测数据信息各自表示不同的患者状态发生时可能发生的冲突的方法。 虽然强调了神经和心脏疾病的治疗，但是该技术可以应用于用植入装置监测和治疗任何医学障碍。

公开(公告)号：US08805498B1

公开(公告)日：2014-08-12

申请号：US12624515

申请日：2009-11-24

申请人： David R. Fischell ,  Michael Sasha John ,  David Keenan

发明人： David R. Fischell ,  Michael Sasha John ,  David Keenan

IPC分类号： A61N1/362

CPC分类号： A61N1/37247 ,  A61N1/056 ,  A61N1/36592

摘要： A device for detecting cardiac ischemia is disclosed. The device includes a processor that is configured to distinguish between two different heart beats types such as ventricularly paced beats and supraventricular beats. The processor collects separate reference data for each beat type indicative of the normal values of a cardiac feature associated with these beat types. The processor performs an ischemia test by separately comparing present values of the cardiac feature for each beat type with the reference values for the corresponding beat type.

摘要翻译： 公开了一种用于检测心脏缺血的装置。 该装置包括处理器，其被配置为区分两种不同的心跳类型，例如心室起搏节拍和室上搏动。 处理器针对指示与这些节拍类型相关联的心脏特征的正常值的每个节拍类型收集单独的参考数据。 处理器通过将每个节拍类型的心脏特征的当前值与相应节拍类型的参考值分开比较来执行缺血测试。